THC

Expert Voices: Cannabis use in people with multiple sclerosis

In this installment of our “Expert Voices” series, Multiple Sclerosis News Today asked Thorsten Rudroff, PhD, to answer some of your questions about cannabis use with multiple sclerosis. Rudroff is the director of the Integrative Neurophysiology Laboratory and an associate professor in the Department of Health and Human…

Scientists Review State of Cannabis Research in MS

Treatment with cannabis-based medications may ease muscle spasms, decrease pain, and aid in sleep for people with multiple sclerosis (MS), but more research is needed to evaluate the potential benefits of cannabis use. That is the finding of a team of U.S. researchers who published a review paper, “…

The World According to MS Ennui

Move along, move along. Nothing to read here. What a great start to a column! Last week, my worries about MS lifted as I was consumed by a glitch in my computer software. I’m pleased to report that I’ve found a whole series of admittedly fiddly workarounds. I’m even…

On the Healing Powers of THC

I have to admit, I’ve wheeled down the THC path a few times before. Yes, I know it’s very difficult to stay on the path when under the influence. Luckily, I’ve solved this problem by only imbibing in bed. I say imbibing, because for me, smoking the stuff is…

Medical Cannabis Lozenges Now Available for MS Patients in Texas

People in Texas with multiple sclerosis (MS) and other medical conditions now have access to cannabis-infused lozenges, Surterra Texas announced. Under a Texas Compassionate Use Program, cannabis-containing therapies may be prescribed to help treat various neurological and other disorders, including terminal cancer, spasticity,…

Medical Marijuana Now Available to MS and Other Patients in Louisiana

Medical cannabis products, jointly developed by GB Sciences Louisiana (GBSL) and the Louisiana State University Agricultural Center‘s (LSU AgCenter) Therapeutic Cannabis Program, are now available for purchase by qualified patients with illnesses that include multiple sclerosis (MS) at nine state-licensed pharmacies. The decision, announced by the Louisiana Department…

Sativex Can Improve Driving Ability of MS Patients, Study Says

Sativex, a cannabis-based anti-spasticity medicine commercialized as oromucosal spray by GW Pharmaceuticals, improves the driving ability of patients with multiple sclerosis (MS), according to researchers. The findings were published in the journal Brain and Behavior, in a study titled “The influence of THC:CBD oromucosal spray…

Oral Cannabidiol, PTL101, Meets Goals of Phase 1 Study as Possible Spasticity Treatment

Results of a Phase 1 clinical trial in healthy volunteers show that PTL101, an oral cannabidiol compound, is a safe and effectively delivered potential treatment of spasticity in multiple sclerosis (MS) and for conditions like epilepsy, Harvest One Cannabis announced. These findings were published in the journal Clinical Pharmacology in Drug Development, in the study…

Is Medical Marijuana Right for My MS?

The state where I live has legalized medical marijuana (MMJ) and it’s getting ready to open state-licensed marijuana dispensaries. So, I’ve been thinking about using MMJ to treat some of my MS symptoms. How can MMJ help MS patients? A 2012 study by researchers at the University…

AXIM Obtains More Financing for Its Cannabinoid Therapies for MS and Bowel Diseases

AXIM Biotechnologies has secured an additional $4 million in institutional financing to advance clinical trials of its cannabinoid therapies for multiple sclerosis (MS) and irritable bowel syndrome. Some of the trials involve a chewing-gum therapy delivery system. The financing will let the company continue developing a patented chewing-gum-delivered therapy for pain and spasticity. AXIM…

Researchers Test Medical Cannabis as Treatment for MS-Linked Neuropathic Pain

Canadian researchers are testing mice to see if cannabinoid oil products — a common medical marijuana treatment — could help alleviate the neuropathic pain that often afflicts patients with multiple sclerosis (MS). The preclinical study, “Identifying the molecular mechanisms involved in supressing multiple sclerosis induced neuropathic pain following cannabinoid treatment in…